NCT07102394 2026-02-17
Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1
Johns Hopkins University
Phase 1 Recruiting
Johns Hopkins University
Shengjing Hospital
M.D. Anderson Cancer Center
Massachusetts General Hospital
Johns Hopkins University
Ann & Robert H Lurie Children's Hospital of Chicago
Medical College of Wisconsin
University of Alabama at Birmingham